BioSpace News Archive

Drug Development

MabVax Therapeutics Announces Positive Interim Data From Expanded Cohort in Phase 1 Trial Evaluating MVT-5873 in Combination with First-Line Chemotherapy in Pancreatic Cancer

At the dose tested, all six patients in the cohort had meaningful reductions in tumor volume by RECIST.

February 12, 2018

·

5 min read

Business

Covalon Announces Strong First Quarter Financial Results

Total revenue for the three months ended December 31, 2017, was $6,404,705 compared to $5,608,994 for the same period of the prior year.

February 12, 2018

·

6 min read

Genetown

AVEO Announces EUSA Pharma Granted Positive NICE Recommendation for FOTIVDA (tivozanib) as First Line Treatment for Advanced Renal Cell Carcinoma

AVEO announced that the United Kingdom’s National Institute for Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending FOTIVDA® (tivozanib) for the first line treatment of adult patients with advanced renal cell carcinoma (aRCC).

February 12, 2018

·

7 min read

Policy

Announcing a Proposed Class Action Settlement Involving All Persons that Purchased Shares of ARIAD Pharma Publicly Traded Common Stock During Settlement Class Period

To participate in the Settlement, you must submit a Claim Form online using the settlement website .

February 12, 2018

·

3 min read

Business

Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD

The Scientific Advisory Board’s role is to provide scientific guidance and governance for Biostage’s research and development programs.

February 12, 2018

·

6 min read

Lone Star Bio

Stephens & Associates’ Clinical and Business Teams Will be Attending the American Academy of Dermatology’s Annual Meeting in San Diego

The clinical research teams and business leaders from both the Dallas and Phoenix centers will be attending the 2018 American Academy of Dermatology Annual Meeting from February 16 through 20 at the San Diego Convention Center.

February 12, 2018

·

2 min read

Business

Aerie Pharmaceuticals Announces Appointment of Scott Cassady as Regional Sales Director for the Central Region

Aerie announced the appointment of Scott Cassady as Regional Sales Director for the Central Region, reporting to Gary Menichini, Aerie’s Vice President of Sales.

February 12, 2018

·

5 min read

Drug Development

Akebia Therapeutics Provides Update on Vadadustat Development Program

Akebia today provided an update on the global development plan for vadadustat, an oral HIF stabilizer in global Phase 3 development for the treatment of anemia due to chronic kidney disease.

February 12, 2018

·

7 min read

Drug Development

Can-Fite BioPharma Announces New Pre-Clinical Data Supporting a Novel Anti-NASH Mechanism of Action for Namodenoson

Can-Fite BioPharma announced today that pre-clinical studies show Namodenoson’s novel mechanism of action which entails de-regulation of 3 key signaling pathways which mediate the etiology and pathology of NAFLD/NASH and are responsible for the anti-inflammatory and anti-fibrogenic effect in the liver.

February 12, 2018

·

7 min read

Business

Bonti Appoints Dr. Jacob Chacko to Board of Directors

Bonti today announced the appointment of Dr. Jacob Chacko to its Board of Directors, effective immediately.

February 12, 2018

·

2 min read